During the past decade, Seoul National University College of Medicine conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 5 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seoul National University College of Medicine" #1 sponsor was "Seoul National University Hospital" with 10 trials, followed by "Allergan" with 1 trials sponsored, "Chong Kun Dang Pharmaceutical" with 1 trials sponsored, "Emory University" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seoul National University College of Medicine" #1 collaborator was "Asan Medical Center" with 2 trials as a collaborator, "Inje University" with 2 trials as a collaborator, "Severance Hospital" with 2 trials as a collaborator, "Ulsan University Hospital" with 2 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Seoul National University College of Medicine" are "Coronary Artery Disease" (3 trials), "Non-Hodgkin Lymphoma" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Advanced Solid Tumors" (1 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Seoul National University College of Medicine" in a lesser frequency.

Most popular intervention types in "Seoul National University College of Medicine" are "Drug" (15 trials), "Biological" (3 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Active control" (2 trials), "Busulfan, etoposide, cytarabine, and melphalan" (2 trials), "Placebo" (2 trials), "ALLO-ASC(allogeneic adipose derived mesenchymal stem cell) injection" (1 trials) and "Adenosine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seoul National University College of Medicine" are 19 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Seoul National University College of Medicine". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Seoul National University College of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Seoul National University College of Medicine, 3 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".